Evidence of meeting #48 for Health in the 41st Parliament, 2nd Session. (The original version is on Parliament’s site, as are the minutes.) The winning word was pmra.

A recording is available from Parliament.

On the agenda

MPs speaking

Also speaking

Clerk of the Committee  Mr. Andrew Bartholomew Chaplin
Jan Dyer  Director, Government Relations, Canadian Canola Growers Association
Pierre Petelle  Vice-President, Chemistry, CropLife Canada
Corey Loessin  Vice-Chair, Board of Directors, Saskatchewan Pulse Growers, Pulse Canada
Gord Kurbis  Director, Market Access and Trade Policy, Pulse Canada

5:10 p.m.

Vice-Chair, Board of Directors, Saskatchewan Pulse Growers, Pulse Canada

Corey Loessin

I would like to say it's important for farmers to know the rules. We accept that prior to being shipped to India or China or wherever it's headed for, all of our product gets commingled with 100 other farmers' product, so if those 100 farmers know the rules that are available, know the tools, and know how to use them, that's the best-case scenario from our point of view. If international limits are set so that farmers know what is allowed and what isn't, that is the best-case scenario for keeping the product uniform and safe.

5:10 p.m.

Conservative

James Lunney Conservative Nanaimo—Alberni, BC

When there is a lack of regulatory oversight or regulatory capacity, shall we say, in some of the countries we may be exporting to, that creates challenges there as well as for educating farmers.

5:10 p.m.

Vice-Chair, Board of Directors, Saskatchewan Pulse Growers, Pulse Canada

Corey Loessin

Absolutely and, as we mentioned, it's going to get increasingly complex as testing becomes more precise and as countries that are importing product become more sophisticated in their purchasing. It is going to become an increasing challenge and it will likely never go away. It's one we're always going to have to be vigilant on.

5:10 p.m.

Conservative

James Lunney Conservative Nanaimo—Alberni, BC

Thank you.

5:10 p.m.

Conservative

The Chair Conservative Ben Lobb

Ms. Fry.

February 3rd, 2015 / 5:10 p.m.

Liberal

Hedy Fry Liberal Vancouver Centre, BC

I'd like to go back to what Mr. Rankin was talking about. Originally when I asked you the question, I talked about the fact that the major reason for this particular act is to look at health and environmental effects, and to ensure that the safety to people and the environment is paramount.

I also asked about whether harmonization has brought us down to a lowest common denominator. I am a little concerned because I'm hearing about people moving away from Codex, which was the best form of harmonization—the World Health Organization looked at everyone having some fairly clear guidelines—and moving into creating their own regional guidelines or block guidelines, etc. For me, that means there is going to be a big differential between the kinds of safety measures and environmental measures that we see.

I want to go back to this. I brought up Sri Lanka and Mexico, where we see a lot of illnesses caused by people who use pesticides, etc., on foods that we are sent here, and which in the name of trade.... I have no problem with trade. Of course we're a trading nation; we need to trade. At the same time, I do have a problem with the talk about bees and how Europe is using a different set....

I mean, I'm a physician. Looking at drugs, there are very clear international guidelines, and we see what happens when anyone strays from them. An example is that sometimes Canada is very slow to accept certain drugs that other countries have accepted, and the reason is that Canada is working really hard to try to make sure there are no adverse effects. I'm a little concerned that what other countries have found—especially very developed countries, like in Europe, which has very rigid and high levels of safety in terms of health and the environment—is dismissed.

We hear these concerns in Canada, and we are being told, “Well, you know, they're using different methods.” Surely to goodness in pesticide testing, and in the use of pesticides and other ways of looking at sustainable farming around the world, there has to be some clear decision about which is the best way of having an international standard. Again, to me, Codex seems to be that.

The argument that we would look at this every 15 years does not leave me, as a physician, with a lot of hope about human health effects. That 15 years is a long time; 15 years is almost a generation. Do you not regularly do adverse reporting in terms of risks? Is there no way of ensuring that people are checking every two years, that physicians can write in and say, “We're suddenly seeing these kinds of effects and we have reason to believe it is your pesticides.”

Look at the whole lawn issue. Pesticides on the lawn created a massive backlash in Canada, and now municipalities have been setting different standards for looking at pesticides on lawns.

The precautionary principle is something you talked about, but the precautionary principle, surely to goodness, is about human health and safety. Could Canada not follow its drug regulatory mechanism where it won't allow a drug that it doesn't think is safe, rather than saying, “I'm going to allow you to have it, and if I see problems three years later...”? Isn't that closing the stable door after the horse has bolted?

The bottom line is that even if you don't care about the environment, you don't want adverse effects on human beings. Wouldn't it be better to say “Because we're hearing different reports from different countries, we may want to hold off”, rather than the other way around? Mr. Lobb spoke about this, and he said that it's good that people are relooking at things.

My question is on allowing something to occur and relooking at it to see adverse effects, as opposed to not allowing it—as we do with drugs—because we're not sure we have good enough results based on outcomes, not on process.

5:15 p.m.

Vice-President, Chemistry, CropLife Canada

Pierre Petelle

Drugs are a good example, and I would argue that the pesticide regulatory system is very analogous to the drug review and that the pre-market assessment is virtually identical in terms of requirements. In fact, we have an additional requirement because we have to do environmental fate as well, which drugs don't have to do.

In terms of adverse effects, this new act brought those requirements into legislation. Our members are obligated to provide any report that they get to PMRA. Also, any member of the public, doctors or anybody, can provide information as well, through the voluntary incident reporting systems.

Those measures are there. In fact, to characterize it as registering and then seeing what happens, I would say is not a fair characterization. I would say that your requirements on the pre-market assessment are extremely rigid and very analogous to the pharmaceutical world.

5:15 p.m.

Liberal

Hedy Fry Liberal Vancouver Centre, BC

Yet we have the Auditor General saying that our post-market assessments and post-market surveillance in terms of drugs for humans are very different. What happens? I think for me that's the question. It's one thing to have something registered in law and say that you're supposed to do it in regulations, but does it happen?

The Auditor General said that we're not doing a very good job on adverse reporting on drugs. We're waiting. There are drugs that have been on the market for three years and nobody has bothered to act. The regulatory body has not bothered to act on this soon enough or to inform patients “and/or”,yet in Europe there is a very open and transparent way of doing this.

I understand the need to find balance between creating strong and viable agricultural products that we trade in—absolutely, good grief. It's an economic thing. But how do we really find the balance? I would like to hear that balance spoken to differently rather than being told that it's all working very well and everything is fine. I don't know of any system that's working well that isn't fine.

I don't know what happens to adverse reporting. I don't know if it's dismissed, because you told me it's 15 years before somebody re-evaluates, or at least that's what I heard you say. I need to clarify this, because my concern is about human health and safety.

5:20 p.m.

Conservative

The Chair Conservative Ben Lobb

A brief response, please, because we are over the time.

5:20 p.m.

Vice-President, Chemistry, CropLife Canada

Pierre Petelle

Yes. Just to clarify, 15 years is the absolute limit in the sense that if there is no other major evaluation of that product or no major new use of that product, at minimum in 15 years it will be re-evaluated. But if anything comes in in the meantime, whether it is incident reporting or new data from any source, that 15-year timeline is not.... Any new information is what takes precedence. That 15 years is the extreme end of the review.

In reality, what happens is that most companies will add a new use, for example, or a new crop, and that will require new data. The products are generally always being looked at with fresh data.

5:20 p.m.

Conservative

The Chair Conservative Ben Lobb

Mr. Kurbis, a brief response, and then we'll get to Ms. Moore.

5:20 p.m.

Director, Market Access and Trade Policy, Pulse Canada

Gord Kurbis

In terms of harmonization, I would like to make the comment that my sense of working directly in this area is that we will never get to 100% harmonization, because regulators around the world will encounter situations once in a while where they will have legitimate differences of opinion on how data is to be interpreted.

What I would suggest is that we could achieve 90% of the harmonization objectives we have, without even running into those areas of controversy, just by making regulators around the world aware that there are 18 other countries that have office buildings of biologists just like them, and could they please be aware that each other exists. If we could achieve that, we could go so far, without going into those areas of legitimate differences of opinion.

5:20 p.m.

Conservative

The Chair Conservative Ben Lobb

Thank you very much.

For our last questions of the day, Ms. Moore.

5:20 p.m.

NDP

Christine Moore NDP Abitibi—Témiscamingue, QC

Thank you.

I would like to come back to the idea of independent advice and planning for pesticide use.

Mr. Loessin clearly stated that pesticide use is part of a plan and subject to long-term planning. This use is adjusted based on the circumstances. When something doesn't go as expected and the desired results are not achieved, maybe because a product is no longer available or for some other reason, the plan must be adjusted as a result. There is also the fact that certain large farms or large crops may get help from people who are a little more qualified to do this planning, but other smaller farms may not necessarily have the same resources.

Would it be relevant for the act to include everything relating to advisory services for farmers so that pesticide use planning is the best possible? This should also be done independently to ensure that the best products are used, without farmers being pressured and without information being left out when it comes from one manufacturer in particular.

Ms. Dyer could also answer, since she didn't have time in the last round of questions.

5:20 p.m.

Vice-Chair, Board of Directors, Saskatchewan Pulse Growers, Pulse Canada

Corey Loessin

I can quickly try to address that for you.

Some of the large farms do have agronomists right on staff, as you identified, so they may well have their own in-house agronomic advice. Smaller farms, generally, have access to similar advice provided by independent agrology services. Most retailers would have a licensed agronomist on staff who is capable of delivering impartial advice.

As far as incorporating it right into the act goes, I'm not sure that's required. All of the products are registered, so then crop choices become more a matter of planning and the desires of individual farmers regarding the way they want to farm. When they do make choices, those are registered choices that are applied under strict guidelines. So I think advice is there for virtually any farm, big or small, that wants it or needs it.

5:25 p.m.

Director, Government Relations, Canadian Canola Growers Association

Jan Dyer

I would just add that I think this is one of the things industry does really well. The Canola Council of Canada, for example, in the case of canola, has lots of agronomists on staff. So if you're not a big farmer, if you're a small farmer and you need the advice, you can go to those organizations. They're actually engaged hands-on in giving farmers advice, and in translating information that comes from some of the new product development, from the new products, directly to farmers.

They give independent advice. They really specialize in the area. I think it would be very difficult for a federal organization or a federal act to do that better than individuals at the industry level who are engaged in that business of providing advice. They do a really good job of outreach to growers of all kinds, giving the advice they need. We have crop advisories all the time regarding when to spray. For example, the Canola Council of Canada has a website that tells you about spray to swath. It gives you very precise advice about when you should spray, what times you should spray, and what products you should spray. Farmers have access to that information all the time.

I think that's one of the things that industry does very well. It's facilitated by clear guidelines and an enabling framework from the act. As for the actual hands-on translation and the advice about products, I think we already have a really good system for doing that.

5:25 p.m.

Conservative

The Chair Conservative Ben Lobb

Thank you very much. We've had a good discussion today. Thank you for your time and for answering all the questions.

We're going to adjourn, and we'll see you back here Thursday.

The meeting is adjourned.